128 related articles for article (PubMed ID: 33825412)
1. Clinical observation of Yiqi Qingdu prescription on the treatment of intermediate-stage and advanced non-small-cell lung cancer.
Liang Q; Tang X; Yu J; Xiong M; Zhu H; Xiong L; Zeng R; Yu P
J Tradit Chin Med; 2021 Apr; 41(2):308-315. PubMed ID: 33825412
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study.
Liu J; Lin HS; Hou W; Hua BJ; Zhang PT; Li J; Wang SY; Xie Y; Zhang Y; Xie GR; Zhang MY; Shi WG; Guan NB; Guan TY; Li CH; Lu LY; Zhang Y; Li DR; Liu H
Chin J Integr Med; 2017 Oct; 23(10):733-739. PubMed ID: 27796823
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of short-term therapeutic efficacy of integrated traditional and Western medicine in treating non-small cell lung cancer].
Zhou DH; Lin LZ; Zhou YQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1061-5. PubMed ID: 16398422
[TBL] [Abstract][Full Text] [Related]
4. Treatment of non-small cell lung cancer with Yiqi Buxue prescriptions combined with adjuvant chemotherapy on the cancer therapy-related cardiovascular toxicity: A systematic review and meta-analysis.
Huang H; Liu B; Chen M; Qin Y; Li J; Li S; Xu X
J Ethnopharmacol; 2024 Apr; 323():117665. PubMed ID: 38159818
[TBL] [Abstract][Full Text] [Related]
5. Application of Response Evaluation Criteria of Traditional Chinese Medicine for Solid Tumor in advanced non-small cell lung cancer.
Xue NZ; Fang RM; Lin LZ
Chin J Integr Med; 2014 Dec; 20(12):910-6. PubMed ID: 25428339
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage.
Du QC; Yang KZ; Sun XF
Chin J Integr Med; 2009 Jun; 15(3):184-8. PubMed ID: 19568710
[TBL] [Abstract][Full Text] [Related]
7. [Effect of combination of syndrome differentiation depending treatment and chemotherapy on prognostic factors in treating mid-late patients with non-small call lung cancer].
Li LN; Liu WS; Xu K
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):575-9. PubMed ID: 14503053
[TBL] [Abstract][Full Text] [Related]
8. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
9. [Dynamic observation and clinical significance of integrated traditional Chinese and Western medicine on interleukin-2 system, T cell and erythrocyte immune system in patients of lung cancer].
Fan G; Zong W; Zuo J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Aug; 20(8):586-8. PubMed ID: 11789188
[TBL] [Abstract][Full Text] [Related]
10. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of target artery infusion of verapamil and chemotherapy drugs on advanced non-small cell lung cancer].
Tan YF; Ma HX; Zhao B; Zhang HR
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):486-490. PubMed ID: 32575945
[No Abstract] [Full Text] [Related]
12. [Treating HIV/AIDS patients by shenlin fuzheng capsule and qingdu capsule: an analysis of clinical effectiveness].
Su QJ; Li YZ; Wu WQ; Lu ZZ; Zhang YP; Liu ZW; Li X; Deng X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1476-80. PubMed ID: 24483106
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
[TBL] [Abstract][Full Text] [Related]
14. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
Yu DP; Han Y; Zhao QY; Liu ZD
Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis.
Lu Q; Li CL
Life Sci; 2018 Oct; 210():9-19. PubMed ID: 30145153
[TBL] [Abstract][Full Text] [Related]
16. A study on the efficacy of recombinant human endostatin combined with apatinib mesylate in patients with middle and advanced stage non-small cell lung cancer.
Zhao J; Yu H; Han T; Wang W; Tong W; Zhu X
J BUON; 2019; 24(6):2267-2272. PubMed ID: 31983093
[TBL] [Abstract][Full Text] [Related]
17. [Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor].
Xu CA; Su H; Liu JL; Li L; Zou HW
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):436-41. PubMed ID: 21875484
[TBL] [Abstract][Full Text] [Related]
18. Integrated Chinese-western therapy versus western therapy alone on survival rate in patients with non-small-cell lung cancer at middle-late stage.
Lin G; Li Y; Chen S; Jiang H
J Tradit Chin Med; 2013 Aug; 33(4):433-8. PubMed ID: 24187861
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis].
Bian H; Lv Q; Huang XZ; Hu JL; Yang L; Mao BY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1054-9. PubMed ID: 26591358
[TBL] [Abstract][Full Text] [Related]
20. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
Fan CX; Lin CL; Liang L; Zhao YY; Liu J; Cui J; Yang QM; Wang YL; Zhang AR
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):294-7. PubMed ID: 20510083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
